4DX Stock Overview
Operates as a medical technology company in the United States and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
4DMedical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.45 |
| 52 Week High | AU$1.10 |
| 52 Week Low | AU$0.41 |
| Beta | 1.34 |
| 11 Month Change | -12.62% |
| 3 Month Change | 8.43% |
| 1 Year Change | -42.31% |
| 33 Year Change | -67.86% |
| 5 Year Change | n/a |
| Change since IPO | -71.70% |
Recent News & Updates
Recent updates
Here's Why We're Watching 4DMedical's (ASX:4DX) Cash Burn Situation
Sep 21
We're Keeping An Eye On 4DMedical's (ASX:4DX) Cash Burn Rate
May 084DMedical Limited's (ASX:4DX) CEO Compensation Is Looking A Bit Stretched At The Moment
Oct 26Here's Why We're Not At All Concerned With 4DMedical's (ASX:4DX) Cash Burn Situation
Jun 16We Think 4DMedical (ASX:4DX) Needs To Drive Business Growth Carefully
Feb 01Is 4DMedical (ASX:4DX) In A Good Position To Deliver On Growth Plans?
Oct 18We're Hopeful That 4DMedical (ASX:4DX) Will Use Its Cash Wisely
Jul 05We Think 4DMedical (ASX:4DX) Can Afford To Drive Business Growth
Jan 27Here's Why We're Not Too Worried About 4DMedical's (ASX:4DX) Cash Burn Situation
Jun 05Is 4DMedical Limited's (ASX:4DX) Shareholder Ownership Skewed Towards Insiders?
Feb 20
Shareholder Returns
| 4DX | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -6.3% | 4.7% | 1.5% |
| 1Y | -42.3% | 122.4% | 17.2% |
Return vs Industry: 4DX underperformed the Australian Healthcare Services industry which returned 122.4% over the past year.
Return vs Market: 4DX underperformed the Australian Market which returned 17.2% over the past year.
Price Volatility
| 4DX volatility | |
|---|---|
| 4DX Average Weekly Movement | 14.3% |
| Healthcare Services Industry Average Movement | 8.2% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: 4DX's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: 4DX's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 145 | Andreas Fouras | 4dmedical.com |
4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations.
4DMedical Limited Fundamentals Summary
| 4DX fundamental statistics | |
|---|---|
| Market cap | AU$195.00m |
| Earnings (TTM) | -AU$35.98m |
| Revenue (TTM) | AU$3.75m |
49.2x
P/S Ratio-5.1x
P/E RatioIs 4DX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4DX income statement (TTM) | |
|---|---|
| Revenue | AU$3.75m |
| Cost of Revenue | AU$236.72k |
| Gross Profit | AU$3.52m |
| Other Expenses | AU$39.50m |
| Earnings | -AU$35.98m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.088 |
| Gross Margin | 93.69% |
| Net Profit Margin | -958.34% |
| Debt/Equity Ratio | 0% |
How did 4DX perform over the long term?
See historical performance and comparison